help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0157
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Etgen, A. M.
Right arrow Articles by Acosta-Martinez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Etgen, A. M.
Right arrow Articles by Acosta-Martinez, M.
Endocrinology Vol. 144, No. 9 3828-3835
Copyright © 2003 by The Endocrine Society

Participation of Growth Factor Signal Transduction Pathways in Estradiol Facilitation of Female Reproductive Behavior

Anne M. Etgen and Maricedes Acosta-Martinez

Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461

Address all correspondence and requests for reprints to: Dr. Anne M. Etgen, Department of Neuroscience, F113, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: etgen{at}aecom.yu.edu.

Estradiol (E2) regulates female reproductive behavior (lordosis) by acting on estrogen-sensitive neurons. We recently showed that E2 facilitation of lordosis behavior requires concurrent activation of brain IGF-I receptors. The present study confirmed this finding and sought to identify the downstream signaling pathways involved in estrogen/IGF-I priming of lordosis. Intracerebroventricular infusions of a selective IGF-I receptor antagonist were administered to ovariectomized rats every 12 h beginning 1 h before the first of two daily E2 injections. IGF-I receptor blockade partially inhibits lordosis if the antagonist is infused throughout the 2-d estrogen treatment period but not if it is administered only during the first or last 12 h of estrogen treatment. Because E2 and IGF-I can activate phosphatidylinositol-3-kinase (PI3K) and MAPK, we infused agents that block PI3K and/or MAPK activity as described above. Both PI3K inhibitors (wortmannin and LY294002) and MAPK inhibitors (PD98059 and U0126) partially attenuate lordosis when administered during estrogen priming. None of these drugs modifies lordosis if they are infused only once, during the last 12 h of estrogen treatment. When both wortmannin and PD98059 are infused during E2 priming, lordosis behavior is completely abolished. These data suggest that activation of both PI3K and MAPK by E2 and IGF-I mediates hormonal facilitation of lordosis behavior.




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Dewing, A. Christensen, G. Bondar, and P. Micevych
Protein Kinase C Signaling in the Hypothalamic Arcuate Nucleus Regulates Sexual Receptivity in Female Rats
Endocrinology, December 1, 2008; 149(12): 5934 - 5942.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L. M. Garcia-Segura, B. Lorenz, and L. L DonCarlos
The role of glia in the hypothalamus: implications for gonadal steroid feedback and reproductive neuroendocrine output
Reproduction, April 1, 2008; 135(4): 419 - 429.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. J Todd, G. S Fraley, A. C Peck, G. J Schwartz, and A. M Etgen
Central Insulin-Like Growth Factor 1 Receptors Play Distinct Roles in the Control of Reproduction, Food Intake, and Body Weight in Female Rats
Biol Reprod, September 1, 2007; 77(3): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Jover-Mengual, R. S. Zukin, and A. M. Etgen
MAPK Signaling Is Critical to Estradiol Protection of CA1 Neurons in Global Ischemia
Endocrinology, March 1, 2007; 148(3): 1131 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Vasudevan and D. W. Pfaff
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Endocr. Rev., February 1, 2007; 28(1): 1 - 19.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. Mendez, I. Azcoitia, and L. M. Garcia-Segura
Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms
J. Endocrinol., April 1, 2005; 185(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Gonzalez-Flores, J. Shu, I. Camacho-Arroyo, and A. M. Etgen
Regulation of Lordosis by Cyclic 3',5'-Guanosine Monophosphate, Progesterone, and Its 5{alpha}-Reduced Metabolites Involves Mitogen-Activated Protein Kinase
Endocrinology, December 1, 2004; 145(12): 5560 - 5567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society